194 related articles for article (PubMed ID: 23379700)
1. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.
Huang B; Sun Z; Wang Z; Lu C; Xing C; Zhao B; Xu H
BMC Cancer; 2013 Feb; 13():57. PubMed ID: 23379700
[TBL] [Abstract][Full Text] [Related]
2. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
4. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of patients with Borrmann type IV gastric carcinoma.
Kim DY; Kim HR; Kim YJ; Kim S
ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387
[TBL] [Abstract][Full Text] [Related]
8. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
[TBL] [Abstract][Full Text] [Related]
9. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.
Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
[TBL] [Abstract][Full Text] [Related]
10. Role of bursectomy for advanced gastric cancer: result of a case-control study from a large volume hospital.
Eom BW; Joo J; Kim YW; Bae JM; Park KB; Lee JH; Ryu KW; Kook MC
Eur J Surg Oncol; 2013 Dec; 39(12):1407-14. PubMed ID: 24119717
[TBL] [Abstract][Full Text] [Related]
11. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
13. Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
PLoS One; 2020; 15(1):e0225958. PubMed ID: 31940352
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for peritoneal dissemination of gastric cancer.
Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.
Yin C; Li D; Sun Z; Zhang T; Xu Y; Wang Z; Xu H
Med Oncol; 2012 Jun; 29(2):864-70. PubMed ID: 21298368
[TBL] [Abstract][Full Text] [Related]
18. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal dissemination in early gastric cancer: importance of the lymphatic route.
Yoshida M; Sugino T; Kusafuka K; Nakajima T; Makuuchi R; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M; Kawata N; Tanaka M; Kakushima N; Takizawa K; Ono H
Virchows Arch; 2016 Aug; 469(2):155-61. PubMed ID: 27220762
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
